Kylie O'Keefe | Head of Investor Relations |
Stuart Peltz | Founder and Chief Executive Officer |
Emily Hill | Chief Financial Officer |
Eric Pauwels | Chief Business Officer |
Matthew Klein | Chief Development Officer |
Eric Joseph | JPmorgan |
Joel Beatty | Citi |
Brian Abrahams | RBC |
Vincent Chen | Sanford C. Bernstein |
Joseph Thome | Cowen & Company |
Ladies and gentlemen, thank you for standing by, and welcome to the PTC Fourth Quarter 2020 Financial Results Conference Call. [Operator instructions] I would now like to hand the conference over to your speaker today, Kylie O'Keefe, Head of Investor Relations. Please go ahead, ma'am.
Good afternoon, and thank you for joining us to discuss PTC Therapeutics' fourth quarter and year end 2020 corporate update and financial results.
Joining me on today's call is our Chief Executive Officer, Stuart Peltz; our Chief Financial Officer, Emily Hill, our Chief Development Officer, Matthew Klein and our Chief Business Officer, Eric Pauwels.